C9orf72重复扩增携带者症状前及症状期皮质变薄与表面积丢失加速
基于遗传性额颞叶痴呆倡议队列,纳入386名受试者共640次扫描,比较54例症状性C9orf72携带者、83例无症状携带者与249名对照的皮质厚度和表面积随年龄变化。携带者从30岁早期开始出现线性加速的皮质变薄,解剖分布与症状期萎缩区域相似。
要点
- C9orf72携带者皮质变薄从30岁早期开始加速,早于症状数十年。
- 加速变薄区域与症状期额颞顶叶萎缩分布相似。
- 无症状携带者内侧额顶叶皮质厚度和表面积已减少。
核心结论
- C9orf72重复扩增携带者整个成年期皮质变薄和表面积丢失更快,区域与症状期萎缩一致。
- 致病效应在症状出现数十年前即引起脑结构改变。
研究设计与样本
- 数据来自遗传性额颞叶痴呆倡议,共386名受试者640次扫描。
- 纳入54例症状性C9orf72携带者(72.2%为行为变异型额颞叶痴呆)、83例无症状携带者和249名对照,年龄范围18-86岁。
- T1加权MRI经CIVET 2.1处理提取全顶点皮质厚度和皮质表面积,采用混合效应模型比较,控制人口学变量。
- 通过检验「年龄×遗传状态」交互比较老化轨迹,所有全顶点分析应用错误发现率校正。
主要发现
- 症状性携带者显示大多数额叶及大面积颞顶叶区域皮质厚度/表面积对称性减少。
- 无症状携带者在内侧额顶叶较局限区域及散在的外侧额叶、顶叶和颞叶区域皮质厚度/表面积减少。
- 携带者整个成年期皮质变薄线性更快,差异在30岁早期出现,解剖分布相似。
- 携带者皮质表面积减少更快,主要位于腹侧额叶区域。
临床怎么用
- 对于C9orf72重复扩增携带者,可在症状前阶段关注皮质厚度和表面积加速丢失的影像学标志。
- 皮质变薄加速区域与症状期萎缩区域相似,有助于理解临床前期脑结构改变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: C9orf72 expansion is the most common genetic cause of frontotemporal dementia (FTD). We examined aging trajectories of cortical thickness (CTh) and surface area in C9orf72 expansion adult carriers compared to healthy controls to characterize preclinical cerebral changes leading to symptoms. METHODS: Data were obtained from the Genetic Frontotemporal Dementia Initiative. T1-weighted magnetic resonance imaging scans were processed with CIVET 2.1 to extract vertex-wide CTh and cortical surface area (CSA). Symptomatic and presymptomatic subjects were compared to age-matched controls using mixed-effects models, controlling for demographic variables. Aging trajectories were compared between carriers and noncarriers by testing the "age by genetic status" interaction. False discovery rate corrections were applied to all vertex-wide analyses. RESULTS: The sample included 640 scans from 386 subjects, including 54 symptomatic C9orf72 carriers (72.2% behavioral variant FTD), 83 asymptomatic carriers, and 249 controls (age range = 18-86 years). Symptomatic carriers showed fairly symmetric reduction in CTh/CSA in most of the frontal lobes, in addition to large temporoparietal areas. Presymptomatic subjects had reduced CTh/CSA in more restricted areas of the medial frontoparietal lobes, in addition to scattered lateral frontal, parietal, and temporal areas. These differences were explained by faster cortical thinning linearly throughout adulthood in a similar anatomical distribution, with differences emerging in the early 30s. CSA reduction was also faster in mutation carriers predominantly in the ventrofrontal regions. INTERPRETATION: C9orf72 mutation carriers have faster cortical thinning and surface loss throughout adulthood in regions that show atrophy in symptomatic subjects. This suggests that the pathogenic effects of the mutation lead to structural cerebral changes decades prior to symptoms. ANN NEUROL 2020 ANN NEUROL 2020;88:113-122.
引用
- Le Blanc G, Jetté Pomerleau V, McCarthy J, et al. Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers. Ann Neurol. 2020. PMID: 32285980. doi:10.1002/ana.25748
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。